Clinical Trials · NCT04070209
Management of Oligoprogressive Castration Resistant Prostate Cancer (PCS X)
- Phase
- Phase 2
- Recruitment status
- Active Not Recruiting
- Sponsor
- Sir Mortimer B. Davis - Jewish General Hospital
- Enrollment
- 66
- Start date
- Oct 2020
- Locations
- 11 sites, Canada
- Primary endpoint
- Radiographic Progression-free Survival